Back to search
FDAFDA · Food and drugs·Recall number D-0195-2025

Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.

Published January 22, 2025 · Recall initiated: December 12, 2024

Summary

FDA records drug Class III recall D-0195-2025, published January 22, 2025 and initiated December 12, 2024. Recalling firm: Akron Pharma, Inc.; Status: Ongoing; Reported quantity: 14825 bottles; Lot: Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akron Pharma, Inc.
Distributor
Nationwide in the US
Lot
Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01. recalled?

Yes. FDA published recall D-0195-2025 on January 22, 2025. Reported hazard: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What should I do if I have this product?

Voluntary: Firm initiated · Letter